Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes
Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. P H Yu and D M Zuo Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada. Abstract Methylamine was observed to be deamin...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 42; no. 4; pp. 594 - 603 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
American Diabetes Association
01.04.1993
|
Online Access | Get full text |
Cover
Loading…
Summary: | Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells.
Possible consequences for diabetes.
P H Yu and
D M Zuo
Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada.
Abstract
Methylamine was observed to be deaminated by several semicarbazide-sensitive amine oxidases, which were prepared from blood
and vascular tissues of various species, including humans. Although methylamine itself is relatively nontoxic toward endothelial
cells obtained from both human umbilical vein and calf pulmonary artery, it becomes very toxic in the presence of SSAO. SSAO
inhibitors (i.e., MDL-72974A) effectively protected the cells from methylamine-SSAO-induced damage. The cytotoxicity seems,
therefore, to be a consequence of the deamination of methylamine. Our findings suggest that formaldehyde, the deaminated product
of methylamine, may be responsible for these toxic effects. Human serum, which also contains SSAO, was also capable of deaminating
methylamine and causing cytotoxicity to cultured endothelial cells. Both methylamine and SSAO circulate in human blood, and
their concentrations in the blood of normal healthy subjects are quite close to those required to induce cytotoxicity in tissue-cultured
cells. Both SSAO activity and methylamine levels have been reported to be increased in the blood of diabetic individuals.
Blood SSAO activity also has been reported to be elevated in the blood of STZ-induced diabetic rats. It is possible, therefore,
that an abnormal metabolism of methylamine may be involved in endothelial injury, and that it may subsequently induce atherosclerotic
plaque formation and thus be involved in the cardiovascular disorders seen in diabetes. |
---|---|
ISSN: | 0012-1797 1939-327X 0012-1797 |
DOI: | 10.2337/diabetes.42.4.594 |